NIKIA FISHBACK: Open Payments
NPI 1487235412 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 22 payments from 10 companies in 2025. Trend: 2023 $585 · 2024 $545 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 5 | $192 |
| SHIELD THERAPEUTICS INC | 5 | $109 |
| Sumitomo Pharma America, Inc. | 4 | $85 |
| Sage Therapeutics, LLC | 2 | $46 |
| Organon LLC | 1 | $24 |
| Davol Inc. | 1 | $19 |
| Exeltis, USA Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: BIJUVA, ACCRUFER, MYFEMBREE, ZURZUVAE, NEXPLANON, ARISTA, SLYND, ZEPBOUND.
Industry payments across KY — which companies pay providers there.
